Literature DB >> 18301137

Role of apoptosis in pressure-overload cardiomyopathy.

Amedeo Anselmi1, Mario Gaudino, Alfonso Baldi, George W Vetrovec, Rossana Bussani, Gianfederico Possati, Antonio Abbate.   

Abstract

In the natural history of pressure overload, the hypertrophy response of the left ventricle initially normalizes wall stress and allows preservation of a normal ejection fraction. Nevertheless, patients progress gradually or suddenly from compensated hypertrophy to ventricular dilation with heart failure. Long-standing hypertrophy entails a maladaptive response, which is due to derangements inherent in the myocardium rather than to a progressive increase in the cause of pressure overload. Despite this condition being linked to major clinical consequences and an unfavourable prognosis, the cellular and molecular mechanisms in pressure-overload cardiomyopathy have not yet been established. This review discusses the available experimental and clinical evidence with respect to the role played by myocardial apoptosis in pressure-overload cardiomyopathy.

Entities:  

Mesh:

Year:  2008        PMID: 18301137     DOI: 10.2459/JCM.0b013e328277f1d7

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  6 in total

1.  Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism.

Authors:  Ying Xia; Marcin Dobaczewski; Carlos Gonzalez-Quesada; Wei Chen; Anna Biernacka; Na Li; Dong-Wook Lee; Nikolaos G Frangogiannis
Journal:  Hypertension       Date:  2011-09-26       Impact factor: 10.190

2.  Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity.

Authors:  Lan He; Teayoun Kim; Qinqiang Long; Jian Liu; Peiyong Wang; Yiqun Zhou; Yishu Ding; Jeevan Prasain; Philip A Wood; Qinglin Yang
Journal:  Circulation       Date:  2012-08-29       Impact factor: 29.690

3.  Apoptosis in severe, compensated pressure overload predominates in nonmyocytes and is related to the hypertrophy but not function.

Authors:  Ricardo J Gelpi; Misun Park; Shumin Gao; Sunil Dhar; Dorothy E Vatner; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

4.  LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice.

Authors:  Dan Lu; Hong Lian; Xiaojuan Zhang; Haitao Shao; Lan Huang; Chuan Qin; Lianfeng Zhang
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

5.  Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?

Authors:  Rania Hammami; Mouna Boudabbous; Jihen Jdidi; Fatma Trabelsi; Fakher Mroua; Rahma Kallel; Ali Amouri; Dorra Abid; Nabil Tahri; Leila Abid; Samir Kammoun
Journal:  Libyan J Med       Date:  2017-12       Impact factor: 1.657

6.  Zinc finger protein 91 loss induces cardiac hypertrophy through adenosine A1 receptor down-regulation under pressure overload status.

Authors:  Xiangqi Wu; Wei You; Zhiming Wu; Fei Ye; Shaoliang Chen
Journal:  J Cell Mol Med       Date:  2020-07-17       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.